Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

Three additions to the interaction checker

Thursday 19 July 2018

Daratumumab, ixazomib and pomalidomide are now listed in the interaction checker as cancer drugs and interactions can be found with all the comedications. 

  • Daratumumab (Darzalex®) is a CD38-directed antibody and is indicated for the treatment of multiple myeloma.
  • Ixazomib (Ninlaro®) is a proteasome inhibitor and is indicated for the treatment of multiple myeloma. 
  • Pomalidomide (Imnovid®) is a thalidomide analogue and is indicated for the treatment of multiple myeloma. 
ENDORSED BY
Bopa